In-Pipe develops technologies for use in the municipal wastewater sector while focusing on increased efficiencies and reduced capital expenditure requirements.
In-Pipe’s patented technology includes the use of natural, biological methods in adding a formulation of facultative, naturally-occurring, non-pathogenic bacteria to strategic locations throughout the sewer system within the wastewater treatment plant in accordance with an engineered plan.
This system requires zero capital cost and no additional energy requirement and is claimed to enhance the performance in the collection system and increase capacity within the wastewater plant, while extending the life of the existing infrastructure.
In-Pipe president and CEO John Williams that the company continues to expand its installed base in North America and the synergistic relationship with Aqua is providing additional growth opportunities off-shore.
